Skip to content
zameds

Amoxycillin (Norimox)

Amoxycillin

Hoechst Marion Roussel Ltd

Every registration of this product has been cancelled.

Registration

Applicant
Hoechst Marion Roussel Ltd
Registrations
4

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Norimox 250

EACH CAPSULE CONTAINS AMOXYCILLIN TRIHYDRATE EQUIVALENT TO 250 mg AMOXYCILLIN

250W0072W/20.1.2/72CancelledNot determinedNone
Norimox 500

EACH CAPSULE CONTAINS AMOXYCILLIN TRIHYDRATE EQUIVALENT TO 500 mg AMOXYCILLIN

500W0264W/20.1.2/264CancelledNot determinedNone
Norimox 125 syrup

EACH 5 ml SYRUP CONTAINAS AMOXYCILLIN TRIHYDRATE EQUIVALENT TO 125 mg AMOXYCILLIN

125SyrupW0265W/20.1.2/265CancelledNot determinedNone
Norimox 250 syrup

EACH 5 ml SYRUP CONTAINAS AMOXYCILLIN TRIHYDRATE EQUIVALENT TO 250 mg AMOXYCILLIN

250SyrupW0266W/20.1.2/266CancelledNot determinedNone

Regulatory status

This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

C16H19N3O5S365.40 g/mol

(2S,5R,6R)-6-[[(2R)-2-Amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid

Drag to rotate. Structure from PubChem CID 33613.

SAHPRA documents

SAHPRA has not published a professional information or patient information leaflet for this product.

Background

Loading...
Loading Wikipedia summary

Research articles

Loading...
Loading PubMed articles